Executive Leadership

Dr. Hongwei Cheng

Dr. Hongwei Cheng, M.D., Ph.D., is a recognized expert in preclinical and translational drug development, known for his pioneering contributions and leadership in advancing biotechnology. As the Founder and CEO of TME Scientific, a Contract Research Organization (CRO), he guides pharmaceutical and biotech companies through the complexities of drug discovery and development. Additionally, Dr. Cheng founded PharmaPlanter Technologies and the Biotech Alliance of Pan Pacific (BioAPP), driving the development of innovative biotechnologies and fostering global scientific collaborations.

Chief Executive Officer

Dr. Na Li M.D, Ph.D.

Chief Technology Officer

Dr. Na Li, an expert in immunology, pathology, and molecular/cancer biology, has conducted graduate and postdoctoral research across China, Japan, the U.S., and Canada. Specializing in immune-related disorders and various cancers, she has made significant contributions to prostate cancer research at the Vancouver Prostate Center, focusing on castration-resistant prostate cancer (CRPC). As the Chief Technology Officer at TME Scientific, Dr. Li leads in vivo and in vitro studies, recombinant protein production, and the development of innovative therapeutic strategies, driving advancements in cancer and immunotherapy research.

Hannah Sanford-Crane Ph.D.

In Vivo Director

Dr. Hannah Sanford-Crane is a preclinical research leader and translational pharmacology expert specializing in in vivo model development, biomarker discovery, and IND-enabling studies. As the Director of In Vivo Lab at TME Scientific, she collaborates with biotech and pharmaceutical partners to design, optimize, and execute high-impact preclinical studies, ensuring strong translational relevance and regulatory success.

Dr. Sunil Joseph is an expert in immunology, cellular and molecular assay development, with a focus on in vitro screening, assay development, and translational research. He has a solid background in both scientific and business aspects of the industry. As the Director of the In Vitro lab at TME Scientific, he collaborates with industry and academic partners to design and implement in vitro assays, integrating translational insights to bridge the gap between discovery and preclinical research.